Eli Lilly Stock Jumps Entry Point As Weight-Loss Drugs Fervor Heats Up – Investor’s Business Daily
The company already sells as obesity treatment, but it’s working on next-generation drugs.
The company already sells as obesity treatment, but it’s working on next-generation drugs.